Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Elmar J. Schnee is a Swiss businessperson who has been at the head of 12 different companies. Presently, Dr. Schnee occupies the position of Non-Executive Chairman for Moleac Pte Ltd., Chairman of Santhera Pharmaceuticals Holding AG, Chairman at Calliditas Therapeutics AB, Chairman at Noorik Biopharmaceuticals AG, Independent Non-Executive Chairman of Clinigen Group Plc and Chairman of Procom RX.

He is also on the board of 7 other companies.

In his past career Dr. Schnee held the position of Non-Executive Director at Cardiorentis AG, Non-Executive Chairman at Advanz Pharma Corp. Ltd., Chairman for Genkyotex SA, Managing Director at Caljem GmbH, Member-Executive Board & General Partner at Merck KGaA President & Chief Executive Officer of Merck Serono SA and Managing Director at Merck Santé SAS (both are subsidiaries of Merck KGaA), Managing Director at Sanofi-Synthélabo Ltd., Managing Director at Fisons Plc, Managing Director at Migliara Kaplan & Associates and Managing Director at UCB Pharma Ltd.

Dr. Schnee received an undergraduate degree and a graduate degree from Schweizerisches Institut für Betriebsökonomie AG.

Current positions of Elmar J. Schnee 
NameTitle Since
Clinigen Group plc
(Biotechnology & Medical Research)
Independent Non-Executive Chairman 2021
Calliditas Therapeutics AB (publ)
Chairman 2019
Santhera Pharmaceuticals Holding AG
Chairman 2017
Moleac Pte Ltd. Non-Executive Chairman 2014
Noorik Biopharmaceuticals AG Chairman -
Procom RX Chairman -
Jazz Pharmaceuticals, Inc. Director 2014
Genpharm Services Director -
MindMaze SA Director -
Mindmaze, Inc. Director -
Damien AG Director -
Damian Pharma AG Director -
Kuste Biopharma SAS Director -

Holdings of Elmar J. Schnee 
Jazz Pharmaceuticals plc (JAZZ)
8,2700.013%1,325,019 USD
Santhera Pharmaceuticals Holding AG (SANN)
12,0000.021%15,824 USD

Elmar J. Schnee: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
05/02ELON MUSK : Musk seeks to put in less money in new Twitter deal financing -sources
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
05/03Stocks rise, U.S. yields slip as markets await Fed rate hike
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
05/03ELON MUSK : Elon Musk plans to take Twitter public again later - WSJ
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
More news

© 2022 People and Ownership :   
Elmar J. Schnee : Connections